Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion via SRSF1 and functions as a biomarker in gastric cancer

Table 2 Association of serum HOXA11-AS with clinicopathological characteristics in patients with gastric cancer

Clinical feature	Cases	Serum HOXA11-AS	P-value
Gender			0.824
Male	57	0.345 ± 0.104
Female	37	0.349 ± 0.091
Age (yr)			0.304
<60	38	0.337 ± 0.111
≥60	56	0.355 ± 0.089
Tumor size (cm)			0.001
<5	59	0.320 ± 0.094
≥5	35	0.391 ± 0.092
TNM stage			0.001
I and II	39	0.250 ± 0.073
III and IV	55	0.415 ± 0.040
Differentiation			0.934
Well and moderate	50	0.346 ± 0.112
Poor	44	0.347 ± 0.084
Invasion depth			0.867
T1 and T2	41	0.348 ± 0.100
T3 and T4	53	0.345 ± 0.099
Lymph node metastasis			0.011
Positive	50	0.377 ± 0.088
Negative	44	0.312 ± 0.100